The anti-thrombotic effects of prostacyclin.
D000818:Animals; D001158:Arteries / Q000187:drug effects; D001241:Aspirin / Q000494:pharmacology; D002318:Cardiovascular Diseases / Q000188:drug therapy; D004176:Dipyridamole / Q000494:pharmacology; D011464:Epoprostenol / Q000096:biosynthesis / Q000502:physiology* / Q000627:therapeutic use; D005227:Fatty Acids / Q000494:pharmacology; D006487:Hemostasis; D006706:Homeostasis; D006801:Humans; D008054:Lipid Peroxides / Q000494:pharmacology; D010974:Platelet Aggregation; D011453:Prostaglandins / Q000502:physiology*; D013927:Thrombosis / Q000097:blood / Q000209:etiology*; D013928:Thromboxane A2 / Q000502:physiology
D005227:Fatty Acids; D008054:Lipid Peroxides; D011453:Prostaglandins; D013928:Thromboxane A2; D004176:Dipyridamole; D011464:Epoprostenol; D001241:Aspirin